Exact Mass: 653.2657

Exact Mass Matches: 653.2657

Found 58 metabolites which its exact mass value is equals to given mass value 653.2657, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Bromocriptine

(4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide

C32H40BrN5O5 (653.2213)


Bromocriptine mesylate is a semisynthetic ergot alkaloid derivative with potent dopaminergic activity. It is indicated for the management of signs and symptoms of Parkinsonian Syndrome. Bromocriptine also inhibits prolactin secretion and may be used to treat dysfunctions associated with hyperprolactinemia. It also causes sustained suppression of somatotropin (growth hormone) secretion in some patients with acromegaly. Bromocriptine has been associated with pulmonary fibrosis. G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CB - Prolactine inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist C26170 - Protective Agent > C1509 - Neuroprotective Agent

   

Rifamycin W-hemiacetal

Rifamycin W-hemiacetal

C35H43NO11 (653.2836)


   

Glucosaminylmuramyl-2-alanine-D-isoglutamine

2-{[2-({2-[(3-{[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-4-yl)oxy]-1-hydroxypropylidene}amino)-1-hydroxypropylidene]amino}-4-(C-hydroxycarbonimidoyl)butanoate

C25H43N5O15 (653.2756)


   

2,6,14-Triacetoxy-1-benzoyloxydihydro-9-nicotinoyloxy-beta-agarofuran

2,6,14-Triacetoxy-1-benzoyloxydihydro-9-nicotinoyloxy-beta-agarofuran

C34H39NO12 (653.2472)


   

1beta,5alpha,11-triacetoxy-7beta-benzoyl-4alpha-hydroxy-8beta-nicotinoyl-dihydroagarofuran|1??,5??,11-Triacetoxy-7??-benzoyl-4??-hydroxy-8??-nicotinoyl-dihydroagarofuran

1beta,5alpha,11-triacetoxy-7beta-benzoyl-4alpha-hydroxy-8beta-nicotinoyl-dihydroagarofuran|1??,5??,11-Triacetoxy-7??-benzoyl-4??-hydroxy-8??-nicotinoyl-dihydroagarofuran

C34H39NO12 (653.2472)


   

14-desoxo-3-O-propionyl-5,15-di-O-acetyl-7-O-nicotinoyl-myrsinol-14beta-acetate

14-desoxo-3-O-propionyl-5,15-di-O-acetyl-7-O-nicotinoyl-myrsinol-14beta-acetate

C35H43NO11 (653.2836)


   

1alpha-nicotinoyloxy-2alpha-acetoxy-6beta-acetoxy-9beta-benzoyloxy-11-acetoxy-4beta-hydroxydihydro-beta-agarofuran|1??-Nicotinoyloxy-2??-acetoxy-6??-acetoxy-9??-benzoyloxy-11-acetoxy-4??-hydroxydihydro-??-agarofuran|2,6,14-Triacetoxy-9-(benzoyloxy)dihydro-1-nicotinoyloxy-beta-agarofuran

1alpha-nicotinoyloxy-2alpha-acetoxy-6beta-acetoxy-9beta-benzoyloxy-11-acetoxy-4beta-hydroxydihydro-beta-agarofuran|1??-Nicotinoyloxy-2??-acetoxy-6??-acetoxy-9??-benzoyloxy-11-acetoxy-4??-hydroxydihydro-??-agarofuran|2,6,14-Triacetoxy-9-(benzoyloxy)dihydro-1-nicotinoyloxy-beta-agarofuran

C34H39NO12 (653.2472)


   
   

2-O-beta-D-glucopyranosyldemethylalangiside

2-O-beta-D-glucopyranosyldemethylalangiside

C30H39NO15 (653.232)


   

His Leu Asp Gln Gln

His Leu Asp Gln Gln

C27H43N9O10 (653.3133)


   

Ferrioxamine E [M+Fe-2H]

Ferrioxamine E [M+Fe-2H]

C27H45FeN6O9 (653.2597)


   

Bromocriptine

Bromocriptine

C32H40BrN5O5 (653.2213)


G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CB - Prolactine inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist C26170 - Protective Agent > C1509 - Neuroprotective Agent

   
   

Fmoc-Trp(Boc)-Ser(psi(Me,Me)pro)-OH

Fmoc-Trp(Boc)-Ser(psi(Me,Me)pro)-OH

C37H39N3O8 (653.2737)


   

tetrasodium N-(3-carboxylato-1-oxo-2-sulphonatopropyl)-N-octadecyl-L-aspartate

tetrasodium N-(3-carboxylato-1-oxo-2-sulphonatopropyl)-N-octadecyl-L-aspartate

C26H43NNa4O10S (653.2198)


   

Precursor of cefcapene diisopropylanmine salt

Precursor of cefcapene diisopropylanmine salt

C29H43N5O8S2 (653.2553)


   

2-[2-[2-[3-Acetamido-5-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoylamino]propanoylamino]-5-amino-5-oxopentanoic acid

2-[2-[2-[3-Acetamido-5-[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoylamino]propanoylamino]-5-amino-5-oxopentanoic acid

C25H43N5O15 (653.2756)


   

(9R)-5-Bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

(9R)-5-Bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

C32H40BrN5O5 (653.2213)


   

(6Ar)-5-bromo-N-[(1S,4R)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

(6Ar)-5-bromo-N-[(1S,4R)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

C32H40BrN5O5 (653.2213)


   

(6aS,9R)-5-bromo-N-[(1R,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

(6aS,9R)-5-bromo-N-[(1R,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

C32H40BrN5O5 (653.2213)


   
   
   

(8S)-2-Bromo alpha-ergocryptine

(8S)-2-Bromo alpha-ergocryptine

C32H40BrN5O5 (653.2213)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   
   
   

ferrioxamine E

ferrioxamine E

C27H45FeN6O9 (653.2597)


An Fe(III)-complexed hydroxamate siderophore consisting of norcardamine (desferrioxamine E) complexed to iron(III).

   
   
   
   
   
   
   
   
   
   

ST 24:4;O8;HexNAc

ST 24:4;O8;HexNAc

C32H47NO13 (653.3047)


   

(1s,2r,4s,5r,6s,7s,8r,9r,12r)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-5-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl pyridine-3-carboxylate

(1s,2r,4s,5r,6s,7s,8r,9r,12r)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-5-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl pyridine-3-carboxylate

C34H39NO12 (653.2472)


   

4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-5-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl pyridine-3-carboxylate

4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-5-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl pyridine-3-carboxylate

C34H39NO12 (653.2472)


   

(3s,4r,4as,5ar)-4-ethenyl-8-hydroxy-3,7-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

(3s,4r,4as,5ar)-4-ethenyl-8-hydroxy-3,7-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

C30H39NO15 (653.232)


   

(1r,2s,4s,5s,6s,7s,9s,12s)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

(1r,2s,4s,5s,6s,7s,9s,12s)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

C34H39NO12 (653.2472)


   

(1s,2s,3s,4r,5r,7s,8s,9s,10s,11r,14s)-2,7,8-tris(acetyloxy)-5,9-dimethyl-11-(prop-1-en-2-yl)-4-(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate

(1s,2s,3s,4r,5r,7s,8s,9s,10s,11r,14s)-2,7,8-tris(acetyloxy)-5,9-dimethyl-11-(prop-1-en-2-yl)-4-(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate

C35H43NO11 (653.2836)


   

2-({2-[(1,3-dihydroxy-2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}propylidene)amino]-1,3-dihydroxypropylidene}amino)-n-{2-[(1-hydroxy-2-oxopiperidin-3-yl)-c-hydroxycarbonimidoyl]ethyl}-5-(n-hydroxyformamido)pentanimidic acid

2-({2-[(1,3-dihydroxy-2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}propylidene)amino]-1,3-dihydroxypropylidene}amino)-n-{2-[(1-hydroxy-2-oxopiperidin-3-yl)-c-hydroxycarbonimidoyl]ethyl}-5-(n-hydroxyformamido)pentanimidic acid

C27H39N7O12 (653.2657)


   

1α-nicotinoyloxy-2α-acetoxy-6β-acetoxy-9β-benzoyloxy-11-acetoxy-4β-hydroxydihydro-β-agarofuran

NA

C34H39NO12 (653.2472)


{"Ingredient_id": "HBIN002312","Ingredient_name": "1\u03b1-nicotinoyloxy-2\u03b1-acetoxy-6\u03b2-acetoxy-9\u03b2-benzoyloxy-11-acetoxy-4\u03b2-hydroxydihydro-\u03b2-agarofuran","Alias": "NA","Ingredient_formula": "C34H39NO12","Ingredient_Smile": "CC(=O)OCC12C(CC3C(C1(C(CC(C2OC(=O)C4=CN=CC=C4)OC(=O)C)(C)O)OC3(C)C)OC(=O)C)OC(=O)C5=CC=CC=C5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15525","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1r,2r,3r,4s,5s,7r,8s,9r,10r,11s,14r)-2,7,8-tris(acetyloxy)-5,9-dimethyl-11-(prop-1-en-2-yl)-4-(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate

(1r,2r,3r,4s,5s,7r,8s,9r,10r,11s,14r)-2,7,8-tris(acetyloxy)-5,9-dimethyl-11-(prop-1-en-2-yl)-4-(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate

C35H43NO11 (653.2836)


   

5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-8-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate

5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-8-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate

C34H39NO12 (653.2472)


   

6,8,15,21,23,27,28-heptahydroxy-3,7,16,20,22,24,29-heptamethyl-26-oxa-14-azatetracyclo[23.2.2.1⁹,¹³.0⁵,¹⁰]triaconta-2,5(10),6,8,12,14,16,18-octaene-4,11,30-trione

6,8,15,21,23,27,28-heptahydroxy-3,7,16,20,22,24,29-heptamethyl-26-oxa-14-azatetracyclo[23.2.2.1⁹,¹³.0⁵,¹⁰]triaconta-2,5(10),6,8,12,14,16,18-octaene-4,11,30-trione

C35H43NO11 (653.2836)


   

(1s,2s,5s,6s,7s,8r,9r,12r)-5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-8-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate

(1s,2s,5s,6s,7s,8r,9r,12r)-5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-8-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate

C34H39NO12 (653.2472)


   

2,7,8-tris(acetyloxy)-5,9-dimethyl-11-(prop-1-en-2-yl)-4-(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate

2,7,8-tris(acetyloxy)-5,9-dimethyl-11-(prop-1-en-2-yl)-4-(propanoyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate

C35H43NO11 (653.2836)


   

(4r,7r)-10-bromo-n-[(1s,2s,4r,7s)-2-hydroxy-4-isopropyl-7-(2-methylpropyl)-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

(4r,7r)-10-bromo-n-[(1s,2s,4r,7s)-2-hydroxy-4-isopropyl-7-(2-methylpropyl)-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

C32H40BrN5O5 (653.2213)


   

(2r)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-2-[2-(2-hydroxyphenyl)-2-oxoethoxy]ethylidene]amino}-1,3-dihydroxypropylidene]amino}-n-(2-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-5-(n-hydroxyformamido)pentanimidic acid

(2r)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-2-[2-(2-hydroxyphenyl)-2-oxoethoxy]ethylidene]amino}-1,3-dihydroxypropylidene]amino}-n-(2-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-5-(n-hydroxyformamido)pentanimidic acid

C27H39N7O12 (653.2657)


   

(1s,2s,4s,5r,6r,7s,9r,12r)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

(1s,2s,4s,5r,6r,7s,9r,12r)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

C34H39NO12 (653.2472)


   

4-ethenyl-8-hydroxy-3,7-bis({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

4-ethenyl-8-hydroxy-3,7-bis({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

C30H39NO15 (653.232)


   

(2z,16z,18e,20s,23r,25s,27s,28r)-6,8,15,21,23,27,28-heptahydroxy-3,7,16,20,22,24,29-heptamethyl-26-oxa-14-azatetracyclo[23.2.2.1⁹,¹³.0⁵,¹⁰]triaconta-2,5,7,9,12,14,16,18-octaene-4,11,30-trione

(2z,16z,18e,20s,23r,25s,27s,28r)-6,8,15,21,23,27,28-heptahydroxy-3,7,16,20,22,24,29-heptamethyl-26-oxa-14-azatetracyclo[23.2.2.1⁹,¹³.0⁵,¹⁰]triaconta-2,5,7,9,12,14,16,18-octaene-4,11,30-trione

C35H43NO11 (653.2836)


   

(2r)-2-{[(2s)-2-{[(2s)-1,3-dihydroxy-2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}propylidene]amino}-1,3-dihydroxypropylidene]amino}-n-(2-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-5-(n-hydroxyformamido)pentanimidic acid

(2r)-2-{[(2s)-2-{[(2s)-1,3-dihydroxy-2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}propylidene]amino}-1,3-dihydroxypropylidene]amino}-n-(2-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-5-(n-hydroxyformamido)pentanimidic acid

C27H39N7O12 (653.2657)


   

4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

C34H39NO12 (653.2472)


   

(2r)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(2-hydroxybenzoyloxy)propylidene]amino}-1,3-dihydroxypropylidene]amino}-n-(2-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-5-(n-hydroxyformamido)pentanimidic acid

(2r)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(2-hydroxybenzoyloxy)propylidene]amino}-1,3-dihydroxypropylidene]amino}-n-(2-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-5-(n-hydroxyformamido)pentanimidic acid

C27H39N7O12 (653.2657)


   

2-{[2-({2-amino-1-hydroxy-2-[2-(2-hydroxyphenyl)-2-oxoethoxy]ethylidene}amino)-1,3-dihydroxypropylidene]amino}-n-{2-[(1-hydroxy-2-oxopiperidin-3-yl)-c-hydroxycarbonimidoyl]ethyl}-5-(n-hydroxyformamido)pentanimidic acid

2-{[2-({2-amino-1-hydroxy-2-[2-(2-hydroxyphenyl)-2-oxoethoxy]ethylidene}amino)-1,3-dihydroxypropylidene]amino}-n-{2-[(1-hydroxy-2-oxopiperidin-3-yl)-c-hydroxycarbonimidoyl]ethyl}-5-(n-hydroxyformamido)pentanimidic acid

C27H39N7O12 (653.2657)